Pharmaresearch Product is trading at 63,400 KRW as of 10:30 AM on the 12th, up 0.63% from the previous day. The trading volume is 10,354 shares, which is 38.91% of the previous day's volume. Pharmaresearch Product is known as a regenerative bio pharmaceutical company.
On October 7, Lee Jeong-gi and Kim Doo-hyun, researchers at Hana Financial Investment, stated, "With third-quarter earnings expected to grow QoQ and YoY due to strong sales across all business divisions, additional sales growth is also anticipated with the full-scale launch of Rejumeite and Rejuran HB. The current main products, Conjuran, Rejuran Healer, and cosmetics, are still in the early stages of growth, and along with continuous diversification of the product portfolio, the company is expected to achieve high growth in the future." They set the target price for Pharmaresearch Product at 93,600 KRW.
Over the past five days, individual investors have net purchased 14,961 shares of Pharmaresearch Product, while foreigners and institutions have net sold 12,995 shares and 8,050 shares, respectively.
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
